{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:57:33Z","timestamp":1787032653020,"version":"build-2736575974"},"reference-count":39,"publisher":"MDPI AG","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Am Podiatr Med Assoc"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In contrast to the narrow indications for living skin equivalents, extracellular matrix biomaterials are clinically used in a wide range of wound-healing applications. Given the breadth of possible uses, the goal of this study was to retrospectively compile and analyze the clinical application and effectiveness of an extracellular matrix biomaterial derived from fetal bovine dermis (PriMatrix; TEI Biosciences, Boston, Massachusetts) in patients treated by a single physician and monitored postsurgically in an outpatient wound care center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective medical record review was conducted of consecutive patients treated from January 2007 through January 2009 with meshed PriMatrix after sharp\/surgical debridement and coverage with standard moist wound therapy dressings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twenty-nine patients and 34 wounds were compiled. All of the wounds were unresponsive to conservative treatment owing to complications, including infection, exposed bone or tendon, and other comorbidities known to delay healing. Wounds included 11 diabetic ulcers, 8 venous stasis ulcers, 10 nonhealing traumatic wounds, and 5 other chronic wounds. Thirty of 34 wounds healed, with four patients lost to follow-up. Mean time to healing for diabetic foot ulcers was 105 days with an average of 2.6 PriMatrix applications. Mean time to healing for venous, traumatic, and other chronic wounds was 74 to 82 days with an average of 1.2 to 1.4 PriMatrix applications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In patients with comorbidities known to delay healing, the implantation of PriMatrix promoted the healing and, ultimately, full reepithelialization of otherwise unresponsive wounds of varied etiology, including those with complications of infection or exposed bone or tendon. (J Am Podiatr Med Assoc 102(3): 223\u2013232, 2012)<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7547\/1020233","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T09:44:34Z","timestamp":1396345474000},"page":"233-239","source":"Crossref","is-referenced-by-count":34,"title":["Acellular Fetal Bovine Dermal Matrix in the Treatment of Nonhealing Wounds in Patients with Complex Comorbidities"],"prefix":"10.3390","volume":"102","author":[{"given":"Eric","family":"Lullove","sequence":"first","affiliation":[{"name":"Private practice, 7301 W Palmetto Park Rd, Suite 201-C, Boca Raton, FL 33433. (E-mail:drericlullove@happyhealthyfeet.com)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","reference":[{"key":"b1-1020233","series-title":"Am J Clin Dermatol","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2165\/00128071-200102050-00005","article-title":"Tissue-engineered skin: current status in wound healing.","volume":"2","author":"Bello, YM","year":"2001","unstructured":"Bello, YM, AFFalabella, and WHEaglstein. :Tissue-engineered skin: current status in wound healing. .Am J Clin Dermatol2::305. ,2001. .10.2165\/00128071-200102050-0000511721649"},{"key":"b2-1020233","series-title":"Arch Surg","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/archsurg.135.6.627","article-title":"Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.","volume":"135","author":"Brem, H","year":"2000","unstructured":"Brem, H, JBalledux, TBloom, et al. :Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing. .Arch Surg135::627. ,2000. .1084335710.1001\/archsurg.135.6.627"},{"key":"b3-1020233","series-title":"Int J Low Extrem Wounds","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/1534734609331597","article-title":"Apligraf in the treatment of neuropathic diabetic foot ulcers.","volume":"8","author":"Edmonds, M","year":"2009","unstructured":"Edmonds, M\n          . :Apligraf in the treatment of neuropathic diabetic foot ulcers. .Int J Low Extrem Wounds8::11. ,2009. .1918999710.1177\/1534734609331597"},{"key":"b4-1020233","series-title":"Diabetes Care","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2337\/diacare.19.4.350","article-title":"Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers.","volume":"19","author":"Gentzkow, GD","year":"1996","unstructured":"Gentzkow, GD, SDIwasaki, KSHershon, et al. :Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. .Diabetes Care19::350. ,1996. .872915810.2337\/diacare.19.4.350"},{"key":"b5-1020233","series-title":"Diabetes Care","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2337\/diacare.26.6.1701","article-title":"The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.","volume":"26","author":"Marston, WA","year":"2003","unstructured":"Marston, WA, JHanft, PNorwood, et al. :The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. .Diabetes Care26::1701. ,2003. .10.2337\/diacare.26.6.170112766097"},{"key":"b6-1020233","series-title":"Diabetes Care","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2337\/diacare.24.2.290","article-title":"Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.","volume":"24","author":"Veves, A","year":"2001","unstructured":"Veves, A, VFalanga, DGArmstrong, et al. :Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. .Diabetes Care24::290. ,2001. .1121388110.2337\/diacare.24.2.290"},{"key":"b7-1020233","series-title":"Wound Repair Regen","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1046\/j.1524-475X.1999.00201.x","article-title":"A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers.","volume":"7","author":"Falanga, V","year":"1999","unstructured":"Falanga, V and MSabolinski. :A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. .Wound Repair Regen7::201. ,1999. .10.1046\/j.1524-475X.1999.00201.x10781211"},{"key":"b8-1020233","series-title":"Dermagraft Human Fibro-blast-Derived Dermal Substitute: Directions for Use","year":"2007","unstructured":"Advanced BioHealing Inc\n           :Dermagraft Human Fibro-blast-Derived Dermal Substitute: Directions for Use. ,Advanced BioHealing Inc. ,Westport, CT. ,2007. ."},{"key":"b9-1020233","series-title":"Apligraf Prescribing Information","year":"2010","unstructured":"Organogensis Inc\n           :Apligraf Prescribing Information. ,Organogensis Inc. ,Canton, MA. ,March2010. ."},{"key":"b10-1020233","series-title":"OASIS Wound Matrix: Instructions for Use","year":"2006","unstructured":"Healthpoint Ltd\/Cook Biotech Inc\n           :OASIS Wound Matrix: Instructions for Use. ,Healthpoint Ltd. ,San Antonio, TX. ,2006. ."},{"key":"b11-1020233","series-title":"GRAFT-JACKET Regenerative Tissue Matrix: Instructions for Use","year":"2009","unstructured":"Wright Medical Technology Inc\/LifeCell Corp\n           :GRAFT-JACKET Regenerative Tissue Matrix: Instructions for Use. ,Wright Medical Technology Inc. ,Arlington, TN. ,August2009. ."},{"key":"b12-1020233","series-title":"Int Wound J","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1742-481X.2006.00209.x","article-title":"The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study.","volume":"3","author":"Brigido, SA","year":"2006","unstructured":"Brigido, SA\n          . :The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. .Int Wound J3::181. ,2006. .10.1111\/j.1742-481X.2006.00209.x16984575"},{"issue":"suppl","key":"b13-1020233","series-title":"Orthopedics","article-title":"Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: a pilot study.","volume":"27","author":"Brigido, SA","year":"s145","unstructured":"Brigido, SA, SFBoc, and RCLopez. :Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: a pilot study. .Orthopedics27 ( suppl:):s145. ,2004. ."},{"key":"b14-1020233","series-title":"Int Wound J","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1742-4801.2005.00099.x","article-title":"Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience.","volume":"2","author":"Martin, BR","year":"2005","unstructured":"Martin, BR, MSangalang, SWu, et al. :Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience. .Int Wound J2::161. ,2005. .1672286510.1111\/j.1742-4801.2005.00099.x"},{"key":"b15-1020233","series-title":"Adv Skin Wound Care","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00129334-200506000-00012","article-title":"Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers.","volume":"18","author":"Niezgoda, JA","year":"2005","unstructured":"Niezgoda, JA, CCVan Gils, RGFrykberg, et al. :Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. .Adv Skin Wound Care18::258. ,2005. .1594231710.1097\/00129334-200506000-00012"},{"key":"b16-1020233","series-title":"Int Wound J","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1742-481X.2009.00585.x","article-title":"Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study.","volume":"6","author":"Reyzelman, A","year":"2009","unstructured":"Reyzelman, A, RTCrews, JCMoore, et al. :Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. .Int Wound J6::196. ,2009. .1936858110.1111\/j.1742-481X.2009.00585.x"},{"key":"b17-1020233","series-title":"J Vasc Surg","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jvs.2005.01.042","article-title":"Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial.","volume":"41","author":"Mostow, EN","year":"2005","unstructured":"Mostow, EN, GDHaraway, MDalsing, et al. :Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. .J Vasc Surg41::837. ,2005. .10.1016\/j.jvs.2005.01.04215886669"},{"key":"b18-1020233","series-title":"Adv Skin Wound Care","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/01.ASW.0000363485.17224.26","article-title":"Randomized comparison of OASIS wound matrix versus moist wound dressing in the treatment of difficult-to-heal wounds of mixed arterial\/venous etiology.","volume":"23","author":"Romanelli, M","year":"2010","unstructured":"Romanelli, M, VDini, and MSBertone. :Randomized comparison of OASIS wound matrix versus moist wound dressing in the treatment of difficult-to-heal wounds of mixed arterial\/venous etiology. .Adv Skin Wound Care23::34. ,2010. .2010111410.1097\/01.ASW.0000363485.17224.26"},{"key":"b19-1020233","series-title":"Clin Podiatr Med Surg","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cpm.2009.08.001","article-title":"Extracellular matrix biomaterials for soft tissue repair.","volume":"26","author":"Cornwell, KG","year":"2009","unstructured":"Cornwell, KG, ALandsman, and KSJames. :Extracellular matrix biomaterials for soft tissue repair. .Clin Podiatr Med Surg26::507. ,2009. .10.1016\/j.cpm.2009.08.00119778685"},{"key":"b20-1020233","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.2106\/00004623-200612000-00015","article-title":"Extracellular matrix bioscaffolds for orthopaedic applications: a comparative histologic study.","volume":"88","author":"Valentin, JE","year":"2006","unstructured":"Valentin, JE, JSBadylak, GPMcCabe, et al. :Extracellular matrix bioscaffolds for orthopaedic applications: a comparative histologic study. .J Bone Joint Surg Am88::2673. ,2006. .1714241810.2106\/00004623-200612000-00015"},{"key":"b21-1020233","series-title":"Am J Vet Res","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2460\/ajvr.69.1.148","article-title":"In vitro and in vivo comparison of five biomaterials used for orthopedic soft tissue augmentation.","volume":"69","author":"Cook, JL","year":"2008","unstructured":"Cook, JL, DBFox, KKuroki, et al. :In vitro and in vivo comparison of five biomaterials used for orthopedic soft tissue augmentation. .Am J Vet Res69::148. ,2008. .10.2460\/ajvr.69.1.14818167101"},{"key":"b22-1020233","series-title":"Adv Drug Deliv Rev","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.addr.2003.08.003","article-title":"Effect of collagen matrices on dermal wound healing.","volume":"55","author":"Ruszczak, Z","year":"2003","unstructured":"Ruszczak, Z\n          . :Effect of collagen matrices on dermal wound healing. .Adv Drug Deliv Rev55::1595. ,2003. .10.1016\/j.addr.2003.08.00314623403"},{"key":"b23-1020233","series-title":"J Pediatr Surg","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0022-3468(85)80210-4","article-title":"Comparison of fetal, newborn, and adult wound healing by histologic, enzyme-histochemical, and hydroxyproline determinations.","volume":"20","author":"Adzick, NS","year":"1985","unstructured":"Adzick, NS, MRHarrison, PLGlick, et al. .Comparison of fetal, newborn, and adult wound healing by histologic, enzyme-histochemical, and hydroxyproline determinations. .J Pediatr Surg20::315. ,1985. .404565410.1016\/S0022-3468(85)80210-4"},{"key":"b24-1020233","series-title":"World J Surg","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00268-002-6737-2","article-title":"Fetal wound healing: current biology.","volume":"27","author":"Bullard, KM","year":"2003","unstructured":"Bullard, KM, MTLongaker, and HPLorenz. :Fetal wound healing: current biology. .World J Surg27::54. ,2003. .10.1007\/s00268-002-6737-212557038"},{"key":"b25-1020233","series-title":"Wound Repair Regen","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1046\/j.1524-475X.1994.20204.x","article-title":"Wound healing in the fetus: possible role for inflammatory macrophages and transforming growth factor-\u03b2 iso-forms.","volume":"2","author":"Longaker, MT","year":"1994","unstructured":"Longaker, MT, KSBouhana, MRHarrison, et al. :Wound healing in the fetus: possible role for inflammatory macrophages and transforming growth factor-\u03b2 iso-forms. .Wound Repair Regen2::104. ,1994. .10.1046\/j.1524-475X.1994.20204.x"},{"key":"b26-1020233","series-title":"Plast Reconstr Surg","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1097\/PRS.0b013e3181eae781","article-title":"Scarless fetal wound healing: a basic science review.","volume":"126","author":"Larson, BJ","year":"2010","unstructured":"Larson, BJ, MTLongaker, and HPLorenz. :Scarless fetal wound healing: a basic science review. .Plast Reconstr Surg126::1172. ,2010. .2088524110.1097\/PRS.0b013e3181eae781"},{"key":"b27-1020233","series-title":"Adv Skin Wound Care","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/01.ASW.0000395038.28398.88","article-title":"Retrospective Comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf).","volume":"24","author":"Karr, JC","year":"2011","unstructured":"Karr, JC\n          . :Retrospective Comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf). .Adv Skin Wound Care24::119. ,2011. .10.1097\/01.ASW.0000395038.28398.88"},{"key":"b28-1020233","series-title":"Wound Care Hyperbaric Med","first-page":"9","article-title":"Repair of a fifth finger crush injury.","volume":"1","author":"Higgs, WR","year":"2010","unstructured":"Higgs, WR\n          . :Repair of a fifth finger crush injury. .Wound Care Hyperbaric Med1::9. ,2010. ."},{"key":"b29-1020233","series-title":"Ostomy Wound Manage","first-page":"44","article-title":"Acellular bovine-derived matrix used on a traumatic crush injury of the hand: a case study.","volume":"55","author":"Dunckel, A","year":"2009","unstructured":"Dunckel, A\n          . :Acellular bovine-derived matrix used on a traumatic crush injury of the hand: a case study. .Ostomy Wound Manage55::44. ,2009. .19864695"},{"key":"b30-1020233","series-title":"J Drugs Dermatol","first-page":"781","article-title":"The use of acellular, fetal bovine dermal matrix for acute, full-thickness wounds.","volume":"7","author":"Wanitphakdeedecha, R","year":"2008","unstructured":"Wanitphakdeedecha, R, TMChen, and THNguyen. :The use of acellular, fetal bovine dermal matrix for acute, full-thickness wounds. .J Drugs Dermatol7::781. ,2008. .18720696"},{"key":"b31-1020233","series-title":"Wound Care Hyperbaric Med","first-page":"8","article-title":"Necrotizing fasciitis with delayed closure.","volume":"1","author":"Higgs, WR","year":"2010","unstructured":"Higgs, WR\n          . :Necrotizing fasciitis with delayed closure. .Wound Care Hyperbaric Med1::8. ,2010. ."},{"key":"b32-1020233","article-title":"Utilizing biologic assimilation of bovine fetal collagen in complex reconstruction.","author":"Neil, J","unstructured":"Neil, J, KJames, and WLineaweaver. :Utilizing biologic assimilation of bovine fetal collagen in complex reconstruction. .Paper presented at: Annual Scientific Conference of the Southeastern Society of Plastic and Reconstructive Surgeons;June 4\u20138, 2011;Naples, FL."},{"issue":"suppl","key":"b33-1020233","series-title":"J Foot Ankle Surg","article-title":"Diabetic foot disorders: a clinical practice guideline (2006 revision).","volume":"45","author":"Frykberg, RG","year":"S1","unstructured":"Frykberg, RG, TZgonis, DGArmstrong, et al. :Diabetic foot disorders: a clinical practice guideline (2006 revision). .J Foot Ankle Surg45 ( suppl:):S1. ,2006. ."},{"key":"b34-1020233","series-title":"Diabetes Care","doi-asserted-by":"publisher","first-page":"692","DOI":"10.2337\/diacare.22.5.692","article-title":"Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis.","volume":"22","author":"Margolis, DJ","year":"1999","unstructured":"Margolis, DJ, JKantor, and JABerlin. :Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis. .Diabetes Care22::692. ,1999. .1033266710.2337\/diacare.22.5.692"},{"key":"b35-1020233","series-title":"Am J Surg","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.amjsurg.2007.06.023","article-title":"Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds.","volume":"195","author":"Apelqvist, J","year":"2008","unstructured":"Apelqvist, J, DGArmstrong, LALavery, et al. :Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds. .Am J Surg195::782. ,2008. .1835579710.1016\/j.amjsurg.2007.06.023"},{"key":"b36-1020233","series-title":"J Managed Care Med","first-page":"13","article-title":"Health economic implications for wound care and limb preservation.","volume":"11","author":"Driver, VR","year":"2008","unstructured":"Driver, VR and JMDe Leon. :Health economic implications for wound care and limb preservation. .J Managed Care Med11::13. ,2008. ."},{"key":"b37-1020233","series-title":"Pharmacoeconomics","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2165\/00019053-200321160-00003","article-title":"The cost effectiveness of Apligraf treatment of diabetic foot ulcers.","volume":"21","author":"Redekop, WK","year":"2003","unstructured":"Redekop, WK, JMcDonnell, PVerboom, et al. :The cost effectiveness of Apligraf treatment of diabetic foot ulcers. .Pharmacoeconomics21::1171. ,2003. .1459443810.2165\/00019053-200321160-00003"},{"key":"b38-1020233","series-title":"Diabetes Care","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.2337\/diacare.27.9.2129","article-title":"Costs of lower-extremity ulcers among patients with diabetes.","volume":"27","author":"Stockl, K","year":"2004","unstructured":"Stockl, K, AVanderplas, ETafesse, et al. :Costs of lower-extremity ulcers among patients with diabetes. .Diabetes Care27::2129. ,2004. .1533347310.2337\/diacare.27.9.2129"},{"key":"b39-1020233","series-title":"Nurs Manage","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/00006247-199607000-00007","article-title":"Quality wound care equals cost-effective wound care: a clinical model.","volume":"30","author":"Bolton, LL","year":"1996","unstructured":"Bolton, LL, LVan Rijswijk, and FAShaffer. :Quality wound care equals cost-effective wound care: a clinical model. .Nurs Manage30::32. ,1996. .10.1097\/00006247-199607000-00007"}],"container-title":["Journal of the American Podiatric Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/japmaonline.org\/view\/journals\/apms\/102\/3\/1020233.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/japma\/article-pdf\/102\/3\/233\/1406584\/1020233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/102\/3\/1020233.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/102\/3\/1020233.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:12:15Z","timestamp":1783505535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1930-8264\/102\/3\/233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":39,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.7547\/1020233","relation":{},"ISSN":["8750-7315","1930-8264"],"issn-type":[{"value":"8750-7315","type":"print"},{"value":"1930-8264","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}